Better trials need shared measurement tools
LinkedIn caption
🛤️ Before studies can build on each other, their measurements need to be dependable.
ARPA-H PROSPR aims to develop assessment tools, markers and feasible trial protocols for age-associated health outcomes. That infrastructure matters: consistent collection, repeatable testing and a clear context of use make results easier to interpret across studies.
A practical question to take from ARDD 2026 is how the next trial can produce evidence another team can use. These tools are being developed, and the working group's recommendations to FDA are proposals for validation, not FDA endorsement or an already universal endpoint.
#ARDD2026 #PROSPR #ClinicalTrials #Healthspan
X caption
🛤️ Better healthspan trials need dependable tools: repeatable assessments, clear context of use and results other teams can interpret. PROSPR is building measurement and trial infrastructure; its recommendations are not FDA endorsement. #ARDD2026 #PROSPR
Credit: Michael DeStefano
Copy and paste the caption manually, then attach the downloaded photo. Nothing is published automatically.
